1 / 44

drug therapy in pregnancy

drugs used in pregnancy

drgamal59
Download Presentation

drug therapy in pregnancy

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. 1 DRUG THERAPY IN PREGNANCY Dr Manjuprasad Moderator : Dr Ravichandra.V

  2. 2 Overview • Introduction • Physiological changes during pregnancy • Placental transfer of drugs • Critical period in fetal development and teratogenesis • FDA categories of drug use in pregnancy • Commonly used drugs • Conclusion

  3. 3 Introduction • More than 50% of pregnant women take prescription or nonprescription (over-the-counter) drugs or use social drugs (such as tobacco and alcohol) or illicit drugs at some time during pregnancy, and use of drugs during pregnancy is increasing. • In general, drugs should not be used during pregnancy unless absolutely necessary because many can harm the fetus. • About 2 to 3% of all birth defects result from drugs that are taken to treat a disorder or symptom.

  4. 4 PHYSIOLOGICAL CHANGES DURING PREGNANCY • BMR increases by 15-20%, weight gain – 11kg, postural changes • GIT changes:- decreased gastric motility & emptying, nausea & vomiting • CVS changes:- CO increases by 40%, plasma volume by 45%, low DBP • Decreased serum albumin levels • Hyper coagulability of blood • Increased GFR & renal blood flow

  5. 5

  6. 6 PLACENTAL TRANSFER OF DRUGS • Rate of transfer of drug across depends on:- ▫ Lipid solubility ▫ Ionization of drug ▫ Molecular size ▫ PPB ▫ pH difference – [7.0 vs 7.4]- ionic trapping of weak basic drugs - morphine

  7. 7 • Further, placenta is capable of metabolizing drugs ▫ Is of little relevance to the mother ▫ But has protective effect on fetus Eg:- prednisolone & hydrocortisone are metabolized to inactive compounds ( prednisone, cortisone )- safer for fetus

  8. 8 Effect of toxic drugs on fetus • No effect • Little effect • Serious fetal toxicity • Spontaneous abortion • Death • Fetal malfunction / malformation

  9. 9 Harmful effects depend on • Nature of drug, dose & its route • Stage of pregnancy at which drug is administered • Genetic constitution & susceptibility of fetus

  10. 10 • Directly on the fetus- abnormal development [ birth defects or death] • Alter the function of the placenta - by constricting blood vessels reducing the blood supply of oxygen and nutrients to the fetus – underweight & underdeveloped baby. • Contract uterus:- - reducing the blood supply to fetus -triggering pre-term labor and delivery.

  11. 11 • Gestation may be divided into 4 stages:- ▫ Stage of blastocyst formation  0- 16 days  A teratogen may either kill embryo by inhibiting cell division  If embryo survives exposure to drug – subsequent development normal  ALL or NONE phenomena

  12. 12 Stage of organogenesis • 17 – 60 days • A teratogen given during this stage – gross structural malformation

  13. 13 ▫ Final stage of histogenesis & maturation  Fetus receives adequate supply of nutrients – growth & development  Teratogens – deleterious effects on growth & development  Eg:- DES – dysplasia , vaginal cancer in the female offspring Exposure to androgens – masculinization of female fetus ▫ Short labour delivery stage  Drug administered during this phase – risk of neonatal toxicity

  14. 14

  15. 15 ‘terato’ ; ‘genesis’ • Originally used – describe congenital malformation grossly visible at birth & caused by a teratogen • Now definition includes ‘structural, biochemical and behavioral abnormalities’

  16. 16 A teratogen to be called as teratogen • It should result in characteristic set of malformation • Exert its effect in particular stage of fetal development • Show dose dependent incidence

  17. 17 HISTORY OF THALIDOMIDE • Originally developed in Germany in 1954 • Introduced as hypnotic & sedative in 1957 • Even recommended in pregnancy as a ‘safe hypnotic’ • Teratogenic testing only in mice embryo cells was done • In 1961- 1st phocomelia case was reported • Drug was withdrawn in 1961

  18. 18

  19. 19 FDA CATEGORIES FOR DRUG USE IN PREGNANCY • 1979, FDA developed a system determining teratogenic risk of drugs based on animals & human studies Divided drugs into 5 categories • Category A • Category B • Category C • Category D • Category X

  20. 20 Category A • Drugs in this category have controlled studies in pregnant women that have failed to demonstrate harm to the fetus in the first trimester & have no evidence of further risk in later trimesters. • folic acid & vitamin B12

  21. 21 Category B • Animal studies have failed to demonstrate a risk to the fetus and but there are no adequate and well controlled studies in pregnant women • acetaminophen, insulin & famotidine

  22. 22 Category-C • Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate & well-controlled studies in humans, • But potential benefits may warrant use of the drug in pregnant women despite potential risks • Pseudoephedrine, fluconazole, ciprofloxacin, fexofenadine, escitalopram, fluoxetine, and bupropion

  23. 23 Category D • There is positive evidence of human fetal risk based on adverse reaction data from controlled studies in pregnant humans, • but potential benefits may warrant use of the drug in pregnant women despite potential risks • Example: phenytoin.

  24. 24 Category -X • Adequate, well controlled or observational studies have been done in pregnant women or in animals and have demonstrated positive evidence of fetal abnormalities. • The use of the product is contraindicated in women who are or may become pregnant. • warfarin, medroxyprogesterone, estrogens & methotrexate

  25. 25 DRUGS WITH PROVEN TERATOGENIC EFFECTS • PHENYTOIN ▫ Fetal hydantoin syndrome ▫ Cleft lip, cleft palate & congenital heart disease • Vitamin A derivatives:- ▫ Isotretinoin, etretinate ▫ Significant risk of spontaneous abortion & risk of many significant anomalies

  26. 26 ACEIs ▫ Renal damage – used in 2nd& 3rdtrimester – oligohydraminos ▫ Anomalies of face, limbs & lungs VALPROATE & CARBAMAZEPINE • Spina bifida • Anencephaly • Encephalocele

  27. 27 WARFARIN • Fetal warfarin syndrome • Nasal hypoplasia, depressed nasal bridge & hemorrhagic disorders in fetus NSAIDS • Premature closure of ductus arteriosus • Oligohydraminos

  28. 28

  29. 29 DRUGS TERATOGENIC EFFECTS Tetracycline Anomalies of teeth & bone Chloramphenicol Gray Baby Syndrome Sulfonamides Hyperbilirubinemia , Jaundice & Kernicterus Aminoglycosides Ototoxicity Danazol & other Androgenic drugs Masculinization of female fetus DES Vaginal carcinoma in female off springs during teens Oral Hypoglycemic drugs Neonatal Hypoglycemia

  30. 30 PRECAUTIONS WHILE PRESCRIBING FOR WOMEN OF REPRODUCTIVE AGE • Enquire whether she is pregnant / likely to be in near future Advised to avoid conception for certain period of time with certain drugs • Isotretinoin – 1 month • Mefloquine – 3 months • Cytotoxic drugs – 1 year • Must be informed to use contraceptive measures when a teratogenic drug is prescribed

  31. 31 PRECAUTIONS WHILE PRESCRIBING DURING PREGNANCY • Treat minor ailments without drugs • Doctor must know the safety potential of the drug he prescribes • Always prefer drug which has been in market over a longer time than a new drug • Make dose adjustment • Discourage patient from OTC drug use • Centered on benefit verses risk potential [ epilepsy]

  32. 32 COMMONLY USED DRUGS IN PREGNANCY ANALGESICS & ANTIPYRETICS:- • Acetaminophen, phenacetin , aspirin • Use of NSAIDs avoided towards end of pregnancy – premature closure of ductus arteriosus ANTIEMETICS:- • Antihistaminics – cyclizine, meclizine • Ondansetron ANTIBIOTICS:- • Beta lactam antibiotics safe

  33. 33 • Nitrofurantoin is safe • Erythromycin is safe ; estolate salts are avoided ANTIAMOEBIC DRUGS:- • Metronidazole can be used ANTIMALARIALS • Chloroquine can be used Rx of acute attacks • Quinine – - chloroquine resistant malaria

  34. 34 ANTI TB DRUGS • isoniazid & ethambutol are safe • Rifampicin avoided as far as possible due to hepato-toxicity may be used as a 3rd drug • Streptomycin is CI – ototoxicity ANTIFUNGAL DRUGS • Nystatin & miconazole – safe in pregnancy • Ketoconazole - CI

  35. 35 ANTIASTHMA DRUGS • Beta agonists[inhaled], glucocorticoids[inhaled] CARDIAC DRUGS • Digoxin & quinidine ANTIHYPERTENSIVES • Methyldopa is DOC • Labetalol IV for sudden decrease in BP ANTICOAGULANT • Heparin

  36. 36 ANTIHELMINTHES:- • Piperazine, pyrantel ANTIEPILEPTICS:- • Adequate seizure control necessary for both fetus & mother health • Phenytoin, phenobarbiturate, carbamazepine • Valproate- CI in pregnancy • Here benefits outweighs risk • Folic acid supplementation given

  37. 37 • COUGH- codeine, diphenhydramine, dextromethorphan • HEART BURN- non systemic antacids • CONSTIPATION:- milk of magnesia, glycerin, bisacodyl • THYROTOXICOSIS:- Propylthiouracil • HYPOTHYROIDISM- Thyroxine • Vaccines

  38. 38 SOCIAL DRUGS IN PREGNANCY Cigarette smoking • LBW • Defects of heart, brain & face • Risk of SIDS, placenta previa, abruptio placenta • Risk of PROM, preterm labour, miscarriages & spontaneous abortion

  39. 39 Alcohol • Fetal alcohol syndrome • Incidence – 1 in 2000 live birth • Facial defects, microcephaly, MR, IUGR, miscarriages Caffeine • Found in beverages, soft drinks • Evidences suggest that consuming caffeine during pregnancy possess a little/ no risk • At high dose – decreases fetal blood flow & iron absorption

  40. 40 Illicit drugs • Cocaine & opiod • Serious complication in developing fetus & unborn • Constricts blood vessels- reduces blood flow to fetus • IUGR, miscarriages, preterm delivery

  41. 41 CONCERN WITH OTC DRUGS • In India due to easy availability of drugs & poor health services Increased proportion of self medication for common complaints • Hence consumers always face a threat to unwanted ADRs & drug- drug interations • Many OTC drugs are unsafe during pregnancy • Women who are / may be / planning to be pregnant must consult a doctor before taking any OTC drug

  42. 42 CONCLUSION • The unique nature of physiology of pregnancy makes treating chronic & acute disorders a challenge • As doctors, it is necessary to counsel patients with complete, accurate and current information on the risks and benefits of using medications during pregnancy • Prescribe drugs that have been in use over newer alternatives • Rx must always be centered on benefit versus risk

  43. 43 REFERENCES  Pharmacological aspects of therapeutics – Goodman and Gilman – 12thedition  Principles of pharmacology Sharma and Sharma 2ndedition  Rang & Dale 7thedition  Textbook of medical pharmacology – Dr.Padmaja Udaykumar – fourth edition  Pharmacology & pharmacotherapeutics – R.S. Satoskar, S.D.Bhandarkar, Nirmala.N.Rege  http://www.merckmanuals.com/home/womens_health_issues/drug_use_during_preg nancy/drug_use_during_pregnancy.html  Basic and clinical pharmacology – Katzung 13thedition  Journals from web

  44. 44 THANK YOU

More Related